About

The Centre for Genome Stability (CGS) is a unique multidisciplinary programme bringing together experts from across The Institute of Cancer Research and The Royal Marsden who work on DNA-damage response and genome instability with clinical experts in the treatment of cancer.

​

Our world-leading centre of excellence aims to understand genetic, epigenetic and proteomic changes to genomic stability in the development of cancer in order to develop biomarkers and therapeutic targets for improved cancer treatment. This will allow us to apply multidisciplinary approaches to address important research questions, thus accelerating discoveries into the causes of tumorigenesis and delivering major clinical impacts, both nationally and internationally.

​